search
Back to results

Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice

Primary Purpose

Muscle Soreness, Delayed-onset Muscle Soreness

Status
Completed
Phase
Phase 2
Locations
Spain
Study Type
Interventional
Intervention
Polyherbal supplement: ReWin(d) vs Placebo
Sponsored by
Natural Origins
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Muscle Soreness focused on measuring DOMS, Fatigue rate, Heart rate variability, Pain, Jump performance

Eligibility Criteria

20 Years - 30 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • > 18 years old
  • Young athletes
  • Training at least 3 times per week
  • Agree not to initiate any new exercise or diet programs during the entire study period
  • Agree not to change their current diet or exercise program during the entire study period
  • Agree not to stretch, utilize ice massage, take anti-inflammatory medications (eg, aspirin, ibuprofen), or use any other treatment for the duration of the trial.

Exclusion Criteria:

  • Previous history of upper extremity injury or knee joint pain
  • Use of anti-inflammatory medications or pain medications 1 week before the screening visit and during the study
  • Daily use of dietary supplements and herbal supplements beginning at the screening visit and during the study
  • Antibiotic use in past 3 months
  • Chronic disease

Sites / Locations

  • European University of Madrid

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

ReWin(d)

placebo

Arm Description

Subjects have to take ReWin(d) capsules (3 times a day, total 2 g/day) during breakfast, lunch and diner, during 4 weeks + 3 days after acute exercice

Subjects have to take Placebo capsules (3 times a day, total 2 g/day) during breakfast, lunch and diner, during 4 weeks + 3 days after acute exercice

Outcomes

Primary Outcome Measures

Effects of ReWin(d) on muscle recovery induced by physical exercise
Sport performance (effectiveness of a jump) after exercise-induced muscle damage

Secondary Outcome Measures

Effects of ReWin(d) on muscle damage induced by physical exercise
Muscle skin temperature monitored by IR-camera.
Effects of ReWin(d) on pain perception induced by physical exercise
Visual Analogue Scale pain perception after exercise-induced muscle damage
Effects of ReWin(d) on fatigue rate induced by physical exercise
Heart Rate Variability assessment after exercise-induced muscle damage
Effects of ReWin(d) on Gut Microbiota
Determination of Microbiota composition by 16S rRNA Sequencing.

Full Information

First Posted
May 20, 2019
Last Updated
May 22, 2019
Sponsor
Natural Origins
Collaborators
European University of Madrid
search

1. Study Identification

Unique Protocol Identification Number
NCT03961022
Brief Title
Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice
Official Title
Effects of Dietary Supplementation With ReWin(d) on the Recovery of Young Athletes Suffering From Delayed-Onset Muscle Soreness Induced by Acute Exercice: A Pilot Randomized, Double-blind, Placebo Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
October 22, 2018 (Actual)
Primary Completion Date
December 21, 2018 (Actual)
Study Completion Date
December 21, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Natural Origins
Collaborators
European University of Madrid

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study will assess the recovery and performance of young athletes suffering from muscle damage induced by physical exercise. Model by comparing the safety and efficacy of ReWin(d) supplemention during 4 weeks to placebo over 72 hours post exercice.
Detailed Description
Double-blind, randomized, placebo controlled, parallel group, pilot safety and efficacy study. 40 healthy young male athetes were randomly assigned to the ReWin(d) or Placebo group. After 4 weeks supplementation (either 2 g daily of ReWin(d) capsules or placebo capsules). the participants were subjected to a 1 hour plyometric exercise session to induce DOMS. At 0 hours, 24 hours, 48 hours and 72 hours post exercise, the volunteers have been assessed to determine: (i) pain perception, (ii) fatigue rate, (iii) sport performance (effectiveness of a jump) and (iv) muscle damage and inflammation by I-R thermography and biomarkers

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Muscle Soreness, Delayed-onset Muscle Soreness
Keywords
DOMS, Fatigue rate, Heart rate variability, Pain, Jump performance

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
Single dose, Randomized, Double Blinded, Placebo-controlled Study
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ReWin(d)
Arm Type
Active Comparator
Arm Description
Subjects have to take ReWin(d) capsules (3 times a day, total 2 g/day) during breakfast, lunch and diner, during 4 weeks + 3 days after acute exercice
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
Subjects have to take Placebo capsules (3 times a day, total 2 g/day) during breakfast, lunch and diner, during 4 weeks + 3 days after acute exercice
Intervention Type
Dietary Supplement
Intervention Name(s)
Polyherbal supplement: ReWin(d) vs Placebo
Intervention Description
Supplementation during 4 weeks + 72 hours post acute exercice
Primary Outcome Measure Information:
Title
Effects of ReWin(d) on muscle recovery induced by physical exercise
Description
Sport performance (effectiveness of a jump) after exercise-induced muscle damage
Time Frame
Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session to induce DOMS
Secondary Outcome Measure Information:
Title
Effects of ReWin(d) on muscle damage induced by physical exercise
Description
Muscle skin temperature monitored by IR-camera.
Time Frame
Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session to induce DOMS
Title
Effects of ReWin(d) on pain perception induced by physical exercise
Description
Visual Analogue Scale pain perception after exercise-induced muscle damage
Time Frame
Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session
Title
Effects of ReWin(d) on fatigue rate induced by physical exercise
Description
Heart Rate Variability assessment after exercise-induced muscle damage
Time Frame
Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session
Title
Effects of ReWin(d) on Gut Microbiota
Description
Determination of Microbiota composition by 16S rRNA Sequencing.
Time Frame
Change from baseline dose after 4 weeks of intervention

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: > 18 years old Young athletes Training at least 3 times per week Agree not to initiate any new exercise or diet programs during the entire study period Agree not to change their current diet or exercise program during the entire study period Agree not to stretch, utilize ice massage, take anti-inflammatory medications (eg, aspirin, ibuprofen), or use any other treatment for the duration of the trial. Exclusion Criteria: Previous history of upper extremity injury or knee joint pain Use of anti-inflammatory medications or pain medications 1 week before the screening visit and during the study Daily use of dietary supplements and herbal supplements beginning at the screening visit and during the study Antibiotic use in past 3 months Chronic disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margarita Perez Ruiz, MD(Res)
Organizational Affiliation
European University of Madrid
Official's Role
Principal Investigator
Facility Information:
Facility Name
European University of Madrid
City
Villaviciosa De Odón
State/Province
Madrid
ZIP/Postal Code
28670
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
32848820
Citation
Dominguez-Balmaseda D, Diez-Vega I, Larrosa M, San Juan AF, Issaly N, Moreno-Perez D, Burgos S, Sillero-Quintana M, Gonzalez C, Bas A, Roller M, Perez-Ruiz M. Effect of a Blend of Zingiber officinale Roscoe and Bixa orellana L. Herbal Supplement on the Recovery of Delayed-Onset Muscle Soreness Induced by Unaccustomed Eccentric Resistance Training: A Randomized, Triple-Blind, Placebo-Controlled Trial. Front Physiol. 2020 Jul 21;11:826. doi: 10.3389/fphys.2020.00826. eCollection 2020.
Results Reference
derived

Learn more about this trial

Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice

We'll reach out to this number within 24 hrs